Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-07-28
1990-08-07
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540355, C07D205085, A61K 31395
Patent
active
049468383
ABSTRACT:
The crystalline anhydrous form of [3S-[3.alpha.(Z), 4.beta.]]-3-[[(2-amino-4-thiazolyl) [(1-carboxy-1-methylethoxy)imino]acetyl]amino]-4-methyl-2-oxo-1-azetidines ulfonic acid is prepared.
REFERENCES:
patent: Re28744 (1986-03-01), Long et al.
patent: 2985648 (1961-05-01), Doyle
patent: 3157640 (1964-11-01), Johnson
patent: 3192198 (1965-06-01), Nayler
patent: 3485819 (1969-12-01), Weisenborn
patent: 3507861 (1970-04-01), Morin
patent: 3655656 (1972-04-01), Van Heyningen
patent: 3819620 (1974-06-01), Dursch
patent: 3905960 (1975-09-01), Clark
patent: 3932386 (1976-01-01), Nescio
patent: 4006138 (1977-02-01), Yang
patent: 4529698 (1985-07-01), Sykes
Monkhouse, Drug Development and Industrial Pharmacy, 10, 1373-1392, 1393 (1984).
Physicians Desk Reference, 1986, pp. 302, 305.
Floyd David
Kocy Octavian R.
Monkhouse Donald C.
Pipkin James D.
Berch Mark L.
E. R. Squibb & Sons Inc.
Gaul Timothy J.
LandOfFree
Crystalline anhydrous aztreonam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline anhydrous aztreonam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anhydrous aztreonam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960763